Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{170712,
        author = {Mr Aditya Vaddi and Ms Bhavana Vaddi and Mrs Sharmila and Dr V Bhaskara Raju},
        title = {THERAPEUTIC STRATEGIES WITH ANTIFUNGAL DRUGS AGAINST BLACK FUNGUS},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {287-292},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=170712},
        abstract = {There have been a lot of reports of “mucormycosis,” sometimes known as the "black fungus," especially in Asian nations like India. The fungus Mucorales is the source of the uncommon angio-invasive disease known as mucormycosis. Black fungus treatment usually involves including Posaconazole, Isavuconazole, and Amphotericin-B. The creation of antifungal medications over 65 years. A major factor contributing to the high levels of morbidity and mortality of fungal infections is the limited number of antifungal drugs (Ostrosky-Zeichner L, 2010).},
        keywords = {Amphotericin, Antifungal drugs, Isavuconazole, Mucormycosis, Polyenes, Posaconazole.},
        month = {December},
        }